FDA To Virtually Convene Orthopedic Panel
The meeting was originally scheduled to meet in-person in April
Executive Summary
In a sign the US FDA is trying to address key issues not related to COVID-19, the agency is bringing together an expert panel almost five months after it was originally slated to meet to discuss classifying a slew of orthopedic devices.
You may also be interested in...
Webcasting The New Norm During COVID-19 As FDA Reschedules Opthalmic AdComm Panel
In a sign of the times, regulators are holding an advisory committee meeting for an ophthalmic device online because of the pandemic.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.
Digital Health Roundup: Exec Chats With Illumina, Bloom, AngelMed; M&A, Funding; FDA Down-Classifies Apps
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights IBM Watson Health’s divestiture and other financing news, Exec Chats with Illumina, AngelMed and Bloom, Philips’ new hand-held ultrasound device and autonomous robotic surgery, as well as the latest FDA news on digital health.